UK

Udit Kumar Das

Active Director Director DIN 03080401
DIN 03080401 First appointment Jun 2010 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2010
Shareholding value •••• Premium profile

About Udit Kumar Das

Data last updated:

Udit Kumar Das is a Director at Jms Medicon Private Limited (since 2010). The company operates in Pharma. Jms Medicon Private Limited reported revenue of ₹7.46 Cr (FY 2024).

DIN 03080401
Primary Designation Director
Industry Pharma
First Appointment 24 Jun 2010
Oldest Company Age 16 yrs
Largest company Jms Medicon Private Limited · ₹7.46 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Jms Medicon Private Limited U51397DL2010PTC204616
Director24 Jun 20102010₹7.46 Cr (FY 2024)Active

Board colleagues of Udit Kumar Das

NameDINCompanyDesignation
Induprava Sahoo07137478Jms Medicon Private LimitedDirector

Directorship timeline

Open interactive timeline →
Jms Medicon Private Limited
Premium access

Shareholding and investment profile for Udit Kumar Das

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Udit Kumar Das

Udit Kumar Das currently holds 1 directorship: Jms Medicon Private Limited (Director, since 24 Jun 2010, revenue ₹7.46 Cr (FY 2024)).

Udit Kumar Das was first appointed on 24 Jun 2010 as Director at Jms Medicon Private Limited.

The current boards of Udit Kumar Das's companies include Induprava Sahoo (Jms Medicon Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available